NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

PFE

Pfizer Inc

Apr 17 • 04:00PM ET

22.14

Dollar change +0.10
Percentage change 0.45	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO SPY IVV VTV XLV VYM VHT COWZ DVY

Scroll to Statements

Index	S&P 500	P/E	15.73	EPS (ttm)	1.41	Insider Own	0.04%	Shs Outstand	5.67B	Perf Week	2.55%
Market Cap	125.57B	Forward P/E	7.33	EPS next Y	3.02	Insider Trans	0.80%	Shs Float	5.67B	Perf Month	-15.53%
Income	8.02B	PEG	-	EPS next Q	0.69	Inst Own	67.39%	Short Float	1.72%	Perf Quarter	-16.42%
Sales	63.63B	P/S	1.97	EPS this Y	-5.01%	Inst Trans	-0.38%	Short Ratio	1.92	Perf Half Y	-24.80%
Book/sh	15.56	P/B	1.42	EPS next Y	2.23%	ROA	3.65%	Short Interest	97.49M	Perf Year	-13.82%
Cash/sh	3.61	P/C	6.13	EPS next 5Y	-1.43%	ROE	9.05%	52W Range	20.92 - 31.54	Perf YTD	-16.55%
Dividend Est.	1.71 (7.70%)	P/FCF	12.77	EPS past 5Y	-13.25%	ROI	5.42%	52W High	-29.80%	Beta	0.59
Dividend TTM	1.69 (7.63%)	Quick Ratio	0.92	Sales past 5Y	17.19%	Gross Margin	66.76%	52W Low	5.86%	ATR (14)	0.77
Dividend Ex-Date	Jan 24, 2025	Current Ratio	1.17	EPS Y/Y TTM	272.80%	Oper. Margin	26.92%	RSI (14)	33.42	Volatility	2.80% 3.30%
Employees	81000	Debt/Eq	0.76	Sales Y/Y TTM	8.77%	Profit Margin	12.60%	Recom	2.43	Target Price	28.94
Option/Short	Yes / Yes	LT Debt/Eq	0.68	EPS Q/Q	112.15%	Payout	119.94%	Rel Volume	1.02	Prev Close	22.04
Sales Surprise	2.38%	EPS Surprise	33.59%	Sales Q/Q	24.66%	Earnings	Apr 29 BMO	Avg Volume	50.79M	Price	22.14
SMA20	-6.67%	SMA50	-11.82%	SMA200	-18.61%	Trades		Volume	51,913,770	Change	0.45%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60
Dec-13-22	Upgrade	Goldman	Neutral → Buy	$47 → $60

Show Previous Ratings

Today 05:45PM	Pfizer (PFE) Laps the Stock Market: Here's Why (Zacks)
05:07PM	Nurix Therapeutics: IRAK4 GS-6971 Isn't Only Protein Degrader With Big Potential (Seeking Alpha)
03:31PM	US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years (Benzinga)
02:50PM	Is Pfizer Inc. (PFE) the Best Large-Cap Value Stock to Buy as the Recession Hits? (Insider Monkey)
01:45PM	Eli Lilly: Cementing Its GLP-1 Empire With Orforglipron's Promising Phase 3 Results (Seeking Alpha)
01:06PM	Loading…
01:06PM	Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings? (Zacks)
12:55PM	Lilly Soars as Study Positions Weight-Loss Pill to Pass Ozempic (Bloomberg)
12:46PM	Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide (Motley Fool)
10:51AM	Vaccine Stocks Rise on Growing Threat of Bird Flu Infections (Zacks)
09:20AM	GSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59 (Zacks)
09:15AM	Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback (Zacks)
09:00AM	Eli Lilly Stock Soars on Oral Weight-Loss Drug Trial Results (Investopedia)
08:10AM	My Dividend Stock Portfolio: New All-Time Dividend Record In March - 100 Holdings With 15 Buys (Seeking Alpha)
05:00AM	CDC panel backs broader use of RSV shots (BioPharma Dive)
03:51AM	Trump Tariff Plunge: 3 Phenomenal Stocks to Buy at Bargain Prices Right Now (Motley Fool)
12:58AM	Loading…
12:58AM	Pfizer: Risks Priced In, Buy The Exceptional Valuation And Yield (Seeking Alpha)
Apr-16-25 04:29PM	Analyst Report: Pfizer Inc. (Morningstar Research)
04:15PM	ACIP Votes to Expand Recommendation for Pfizer's RSV Vaccine ABRYSVO to Include Adults Aged 50 to 59 at Increased Risk of Disease (Business Wire)
03:28PM	Pfizer: Tasty 7% Yield (Seeking Alpha)
09:45AM	Top Cancer Stocks to Buy to Boost Your Portfolio's Health (Zacks)
04:52AM	Valneva SE: Initiating Hold Rating Based On Potentially Limited Upside (Seeking Alpha)
Apr-15-25 09:50PM	Parnassus Value Select ETF Q1 2025 Commentary (Seeking Alpha)
06:53PM	Why Pfizer Stock Topped the Market on Tuesday (Motley Fool)
04:21PM	Viking Therapeutics: Trading The Volatility Of The Weight Loss Drug Market (Seeking Alpha)
02:37PM	Viking Therapeutics' VK2735 Candidate Likely Boosted By Pfizer's Woes (Seeking Alpha)
12:57PM	Pfizer Halts Obesity Pill Development Amid Safety Concerns (Zacks)
12:54PM	Squawk Pod: VA Governor Youngkin on DOGE & $2.2B to Harvard on hold - 04/15/25 Audio Only (CNBC TV)
11:05AM	BofA keeps Neutral on Pfizer after danuglipron failure as core thesis unchanged (TipRanks)
10:43AM	Johnson & Johnson: First Look At Q1 Earnings - Solid Quarter Will Calm Nerves (Seeking Alpha)
10:35AM	Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill (TipRanks)
10:00AM	Loading…
10:00AM	NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback (Zacks)
09:09AM	The Tariff Game Just Changed: 7 Blue-Chip Bargains To Buy Now (Seeking Alpha)
07:39AM	Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight-Loss Pill? (Motley Fool)
Apr-14-25 11:32PM	Trump Initiates Chips and Drug Probes Ahead of More Tariffs (Bloomberg)
05:44PM	Pfizer hits setback in obesity drug race as GLP-1 trial halts (Yahoo Finance Video)
05:15PM	Top Analyst Reports for Bank of America, Chevron & Stryker (Zacks)
03:55PM	Stocks to Watch Monday: Apple, Palantir, Intel, Pfizer (The Wall Street Journal)
01:29PM	Dell stock pops, Pfizer halts GLP-1 pill trial, M&T Bank outlook (Yahoo Finance Video)
12:53PM	Pfizer Inc. (PFE): "Dead Money… Close the Casket," Says Jim Cramer (Insider Monkey)
12:45PM	Pfizer drops obesity pill development after liver injury report (Clinical Trials Arena)
11:18AM	Pfizer's $130B Weight-Loss Dream Just Collapsed (GuruFocus.com)
11:15AM	Pfizer Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk. (Barrons.com)
11:12AM	Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today (Motley Fool)
10:55AM	Pfizer just had a big setback in its race for an Ozempic competitor (Quartz)
10:50AM	Wall Street Lunch: Apple Leads Q1 Global Smartphone Sales (Seeking Alpha)
10:37AM	Pfizer, Nvidia, Intel: Stocks in 30 (Yahoo Finance Video)
10:36AM	Pfizer Halts Development of Weight-Loss Pill (The Wall Street Journal)
10:21AM	Is Pfizer Inc. (PFE) Among the Best Dividend Paying Stocks According to Hedge Funds? (Insider Monkey)
10:13AM	Pfizer Halts Development of Obesity Drug After Patient Sustains 'Liver Injury' (Investopedia)
10:06AM	Pfizer Abandons Obesity Pill After Trial Liver Injury (Bloomberg)
09:53AM	Pfizer discontinues GLP-1 pill trial, stock trades flat (Yahoo Finance)
09:08AM	Summit Therapeutics: Multibillion Dollar NSCLC Potential Faces Growing Competition (Seeking Alpha)
08:41AM	Pfizer ends development of potential pill obesity treatment (Associated Press Finance)
07:44AM	Pfizer Stock Falls. Its Halted Development of New Weight-Loss Drug. (Barrons.com)
07:21AM	Pfizer pulls plug on weight-loss pill, citing trial concerns (Investing.com)
06:45AM	Viking Shares Rocket After Pfizer Drops Obesity Drug Due To Liver Injury (Investor's Business Daily)
06:45AM	Pfizer Scraps Obesity Pill After Potential Drug-Tied Liver Injury (Investor's Business Daily)
06:45AM	Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron (Business Wire)
06:09AM	Stock Market Today: Stocks higher as tech powers through tariff confusion (TheStreet)
Apr-13-25 09:51PM	8 March Raises From Duke's 0.5% To Broadcom At 11.3% (Seeking Alpha)
11:30AM	Pfizer: Don't Make The Same Mistake Buying This Dip Again (Seeking Alpha)
09:15AM	SCHD's Portfolio Shake-Up: What It Means For Investors (Rating Downgrade) (Seeking Alpha)
07:41AM	Buy 9 'Safer' Dividend Dogs Of 23 April Barron's Better Bets Than T-Bills (Seeking Alpha)
01:00AM	Big pharma holds its breath as Trump plots his revenge (The Telegraph)
Apr-12-25 04:18AM	1 Deeply Undervalued Stock to Buy in the Market Correction (Motley Fool)
02:16AM	Pfizer: A Strategy For A Chaotic Implied Volatility (Seeking Alpha)
Apr-11-25 05:45PM	Pfizer (PFE) Advances But Underperforms Market: Key Facts (Zacks)
04:35PM	Is Pfizer Inc. (PFE) A Cheap NYSE Stock to Invest in According to Hedge Funds? (Insider Monkey)
01:20PM	Puma Biotechnology: Initiating Hold Rating With Limited Near-Term Upside And Uncertain Pipeline Potential (Seeking Alpha)
11:33AM	NVAX Stock Tanks as HHS Secretary Raises Concern Over COVID-19 Jab (Zacks)
11:20AM	Novavax slides after RFK Jr. casts doubts about COVID vaccine (TipRanks)
09:00AM	Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock (Zacks)
08:39AM	Novavax: Regulatory Uncertainty Creates Risk And Opportunity For Beaten-Down Vaccine Developer (Seeking Alpha)
03:06AM	6 Stocks With Clear Price Dislocations That I Purchased During Wall Street's Historic Volatility (Motley Fool)
Apr-10-25 01:07PM	Vaxcyte Stock Plummets 56% in a Month: Here's the Reason (Zacks)
12:58PM	S&P, Dow Jones Pharma Names Rattled Again On Trump's Tariffs Whiplash (Investor's Business Daily)
12:01PM	Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks. (Investor's Business Daily)
11:00AM	Pfizer Invites Shareholders to Attend Virtual 2025 Annual Meeting of Shareholders on April 24 (Business Wire)
09:54AM	Protalix BioTherapeutics Is A Strong Buy With Increasing Revenues And A Promising Pipeline (Seeking Alpha)
09:44AM	Pfizer Stock Falls to New 52-Week Low: Should You Buy the Dip? (Zacks)
06:30AM	Next-generation Covid-19 vaccines currently being tested (Clinical Trials Arena)
05:00AM	Zacks.com featured highlights General Motors, JD.com, Pfizer, StoneCo and Enersys (Zacks)
Apr-09-25 06:32PM	Analyst Report: Pfizer Inc. (Morningstar Research)
03:59PM	Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out (Seeking Alpha)
12:03PM	Top Stock Movers Now: Delta, Apple, Eli Lilly, and More (Investopedia)
11:15AM	Delta, Walmart, pharmaceutical stocks: Market Minute (Yahoo Finance Video)
10:52AM	Pfizer: Anticipating A Game-Changer Soon (Seeking Alpha)
10:43AM	Apple, Alibaba, drugmaker stocks: Trending Tickers (Yahoo Finance Video)
10:28AM	Pharma Stocks Sink as Trump Says 'Major' Tariffs Coming to Industry (Investopedia)
10:11AM	Trump says pharmaceutical tariffs may be coming: What to know (Yahoo Finance Video)
10:06AM	Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan (Investor's Business Daily)
10:00AM	Pfizer: Best-In-Class Dividend Yield Together With Dirt Cheap Valuation (Seeking Alpha)
09:57AM	Trump Tariff News: New Tariffs Begin, China Retaliates; Treasury Yields Spike While Delta, Walmart Pull Guidance (Investor's Business Daily)
09:51AM	Novo Nordisk, AbbVie Stocks Slide After Trump Vows Pharma Tariffs (The Wall Street Journal)
08:58AM	5 Low Price-to-Book Stocks to Add to Your Portfolio in April (Zacks)
05:40AM	Trump Says Pharmaceutical Tariffs Coming Very Shortly (Bloomberg)
05:32AM	3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right Now (Motley Fool)
Apr-08-25 06:45PM	Biggest Jumps In Dividend Yields (Seeking Alpha)
06:00PM	Building A $100,000 Dividend Portfolio: Enhancing SCHD With April's Top High-Yield Picks (Seeking Alpha)
05:26PM	Pfizer Stocks Fall to 97 Level Lifts Yield Near 8%. Dividend Looks Safe. (Barrons.com)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 13 '24	Sale	28.66	5,154	147,714	8,582	Aug 14 03:47 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience